Diabetes Board decisions

The Veteran's diabetic retinopathy with cataracts was rated noncompensable (0 percent) prior to March 8, 2021. The Board found no evidence of decreased visual acuity or other visual impairment, or incapacitating episodes.,For diabetes mellitus, type II, the Veteran received a 20 percent rating from April 27, 2007 to February 3, 2021 and a 40 percent rating as of February 3, 2021. The Veteran seeks higher ratings for both periods.

The Board has determined that the Veteran's claims for service connection are remanded due to lack of substantial compliance with prior Board directives and need for additional development.

The Board has remanded the issues of service connection for sudden death syndrome, congestive heart failure, hypertension, right upper extremity myopathy, and diabetes mellitus, type II.,Service connection is denied for tuberculosis or residuals thereof.

The Veteran's cause of death was not due to service or a service-connected disability. The Board found no evidence linking the Veteran's COPD, diabetes mellitus, and costochondritis to his military service or exposure to herbicide agents.

The Board has remanded the case for further development of service personnel records and to clarify the Veteran's periods of active duty, inactive duty training (ACDUTRA), and in-service civilian employment. The claims will be reconsidered based on this additional information.

The Veteran's tinnitus had its onset in service and is granted. The remaining issues are remanded for further development.

The Board has reopened the claims for service connection for ischemic heart disease and diabetes mellitus due to new evidence received. However, further research is needed to determine if the Veteran was exposed to herbicide agents while in service on the USS Enterprise in the Gulf of Tonkin.

The Board has granted service connection for diabetes mellitus, type II, on a presumptive basis due to herbicide agent exposure in the Veteran's military service.

The Veteran's request to reopen his claim for compensation under 38 U.S.C. § 1151 for colon perforation has been granted, and the issue of service connection for diabetes, lumbar spine disability, bilateral knee disability, and hearing loss is remanded.

The Board has remanded the Veteran's claims for service connection for cardiovascular disease and diabetes due to insufficient opinions from previous examiners regarding the onset of these conditions during service.

The claims for service connection of diabetes, hypertension, and herpes were denied. The severance of service connection for moderate degenerative changes at L5/S1 (claimed as lower back pain) was also denied.

The Board has decided to remand the case due to an incomplete VA examination, and further development is needed.

The Veteran has withdrawn his appeals for diabetes mellitus and hypertension, which were previously pending before the Board.

The Board denied an initial evaluation in excess of 20 percent for service-connected diabetes mellitus, type II and a rating in excess of 20 percent for left shoulder disability. The Veteran's diabetes did not require daily insulin or regulation of activities, while his left shoulder disability was rated at the maximum schedular evaluation.

The Veteran's prostate cancer and diabetes are granted as due to herbicide exposure during service.,ED is granted as secondary to the service-connected prostate cancer.

The Board has remanded the Veteran's claims for service connection for obstructive sleep apnea and hypertension due to inadequate opinions regarding the relationship between these conditions and his service-connected disabilities, as well as a failure to consider additional lay evidence submitted by the Veteran.

The Board has determined that the Veteran's death was due to a non-traumatic intracerebral hemorrhage (ICH) and is remanding the case for further evaluation of whether his service-connected disabilities contributed to or caused his death, including considering the effects of his diabetes, Parkinson's disease, and hypertension.

The Veteran's service-connected CAD is currently rated at 10 percent from December 17, 2012 to November 7, 2019 and at 30 percent thereafter. The claim for higher ratings for CAD is denied.,The Veteran's service-connected diabetes mellitus is currently rated at 20 percent. The claim for a higher rating is denied.,The Veteran's service-connected diabetic peripheral neuropathy of the right upper extremity, left upper extremity, and lower extremities are all rated at 10 percent. The claims for higher ratings are denied.

The Veteran's claims for an increased rating for nephropathy and a TDIU are being remanded due to the need for updated VA examinations to assess the current severity of his disabilities.

The Board has denied the Veteran's claim for service connection for COPD and remanded the issue of service connection for diabetes mellitus, type II.